Sign up to save your podcasts
Or
Share 161. Why sharing patents for COVID-19 medicines is not enough
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
161. Why sharing patents for COVID-19 medicines is not enough
Despite the Medicines Patent Pool, COVID-19 treatments remain scarce globally. Prashant Yadav explains what more is needed.
View all episodes
By Chad P. Bown
4.8
313313 ratings
Despite the Medicines Patent Pool, COVID-19 treatments remain scarce globally. Prashant Yadav explains what more is needed.
More shows like Trade Talks
View all
Economist Podcasts
4,163 Listeners
Odd Lots
1,987 Listeners
Trumponomics
350 Listeners
Conversations with Tyler
2,458 Listeners
Foreign Policy Live
599 Listeners
Mark Leonard's World in 30 Minutes
102 Listeners
Sinica Podcast
607 Listeners
ChinaPower
212 Listeners
The President’s Inbox
724 Listeners
The Rachman Review
145 Listeners
The Ezra Klein Show
16,492 Listeners
The New Bazaar
267 Listeners
Ones and Tooze
370 Listeners
The Foreign Affairs Interview
483 Listeners
The Economics Show
149 Listeners